These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 1971599)

  • 1. Beta-adrenoceptor blockade potentiates exercise-induced release of atrial natriuretic peptide.
    Deray G; Berlin I; Maistre G; Martinez F; Legrand S; Carayon A; Prost A; Puech A; Masson F; Legrand JC
    Eur J Clin Pharmacol; 1990; 38(4):363-6. PubMed ID: 1971599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beta-adrenoceptor blockade potentiates acute exercise-induced release of atrial natriuretic peptide by increasing atrial diameter in normotensive healthy subjects.
    Berlin I; Lechat P; Deray G; Landault C; Maistre G; Chermat V; Brouard R; Ressayre C; Puech AJ
    Eur J Clin Pharmacol; 1993; 44(2):127-33. PubMed ID: 8095894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tertatolol potentiates exercise-induced atrial natriuretic peptide release by increasing atrial diameter in healthy subjects.
    Berlin I; Deray G; Lechat P; Maistre G; Landault C; Chermat V; Brouard R; Ressayre C; Puech AJ
    Cardiology; 1993; 83 Suppl 1():16-24. PubMed ID: 7903211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atrial natriuretic peptide contributes to physiological control of lipid mobilization in humans.
    Moro C; Crampes F; Sengenes C; De Glisezinski I; Galitzky J; Thalamas C; Lafontan M; Berlan M
    FASEB J; 2004 May; 18(7):908-10. PubMed ID: 15033935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. beta-blockade, atrial natriuretic peptide and exercise.
    Kantola I; Tarssanen L; Scheinin M; Ruskoaho H; Viinamäki O; Kaila T
    Int J Clin Pharmacol Ther; 1996 Jan; 34(1):12-6. PubMed ID: 8688991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exercise-induced lipid mobilization in subcutaneous adipose tissue is mainly related to natriuretic peptides in overweight men.
    Moro C; Pillard F; de Glisezinski I; Klimcakova E; Crampes F; Thalamas C; Harant I; Marques MA; Lafontan M; Berlan M
    Am J Physiol Endocrinol Metab; 2008 Aug; 295(2):E505-13. PubMed ID: 18559985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of beta-adrenoceptor blockade on atrial natriuretic peptide levels during exercise in angina pectoris.
    Riley M; Elborn JS; Onuoha G; Erwin C; Shaw C; Khan MM; Stanford CF; Nicholls DP
    Br J Clin Pharmacol; 1993 Feb; 35(2):209-12. PubMed ID: 8095150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cicletanine does not affect plasma atrial natriuretic peptide concentration in healthy subjects.
    Berlin I; Deray G; Maistre G; Masson F; Barthelemy C; Legrand JC; Jacobs C
    Eur J Clin Pharmacol; 1990; 39(6):593-4. PubMed ID: 1965645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atenolol improves ventricular function without changing plasma noradrenaline but decreasing plasma atrial natriuretic factor in chronic heart failure.
    Gabrielli O; Puyó AM; De Rosa A; Armando I; Barontini M; Levin G
    Auton Autacoid Pharmacol; 2002; 22(5-6):261-8. PubMed ID: 12866806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of beta-adrenergic blockade on plasma levels of atrial natriuretic peptide during exercise in humans.
    Tsai RC; Yamaji T; Ishibashi M; Takaku F; Hsu ST; Lai CY; Yeh SJ; Hung JS; Wu DL; Lee YS
    J Cardiovasc Pharmacol; 1988 May; 11(5):614-8. PubMed ID: 2455849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of beta 1-adrenoceptor blockade on plasma levels of atrial natriuretic peptide during exercise in normal man.
    Thamsborg G; Sykulski R; Larsen J; Storm T; Keller N
    Clin Physiol; 1987 Aug; 7(4):313-8. PubMed ID: 2887332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute effects of alpha- and beta-adrenoceptor blockade on plasma atrial natriuretic peptides during exercise in elderly patients with mild hypertension.
    Kohno M; Yokokawa K; Yasunari K; Murakawa K; Kurihara N; Takeda T
    Chest; 1991 Apr; 99(4):847-54. PubMed ID: 1826253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differentiation of hemodynamic, humoral and metabolic responses to beta 1- and beta 2-adrenergic stimulation in man using atenolol and propranolol.
    McLeod AA; Brown JE; Kuhn C; Kitchell BB; Sedor FA; Williams RS; Shand DG
    Circulation; 1983 May; 67(5):1076-84. PubMed ID: 6299612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential effects of carvedilol and atenolol on plasma noradrenaline during exercise in humans.
    Herman RB; Jesudason PJ; Mustafa AM; Husain R; Choy AM; Lang CC
    Br J Clin Pharmacol; 2003 Feb; 55(2):134-8. PubMed ID: 12580984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beta 1-adrenoceptor selectivity of single oral doses of bisoprolol and atenolol.
    Chang PC; van Veen S; van der Krogt JA; Vermeij P; van Brummelen P
    J Cardiovasc Pharmacol; 1988 Sep; 12(3):317-22. PubMed ID: 2464104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of selective beta 2-adrenoceptor blockade on serum potassium and exercise performance in normal men.
    Gullestad L; Birkeland K; Nordby G; Larsen S; Kjekshus J
    Br J Clin Pharmacol; 1991 Aug; 32(2):201-7. PubMed ID: 1681847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of bisoprolol and atenolol on endurance exercise capacity in healthy men.
    Vanhees L; Defoor JG; Schepers D; Lijnen P; Peeters BY; Lacante PH; Fagard RH
    J Hypertens; 2000 Jan; 18(1):35-43. PubMed ID: 10678541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of arotinolol on exercise capacity and humoral factors during exercise in normal subjects.
    Mori T; Handa K; Terao Y; Tanaka H; Kiyonaga A; Shindo M; Matsunaga A; Sasaki J; Arakawa K
    Cardiovasc Drugs Ther; 1992 Aug; 6(4):387-90. PubMed ID: 1381611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of beta-adrenergic receptor blockade on atrial natriuretic peptide in essential hypertension.
    Nakaoka H; Kitahara Y; Amano M; Imataka K; Fujii J; Ishibashi M; Yamaji T
    Hypertension; 1987 Aug; 10(2):221-5. PubMed ID: 3038746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Atrial natriuretic peptide response to physical exercise is inhibited by an antagonist of the opioid receptors].
    Lartigue M; Louisy F; Habrioux G; Guezennec CY; Galen FX
    Pathol Biol (Paris); 1989 Sep; 37(7):831-5. PubMed ID: 2561015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.